MedPath

Expanding Innovations Receives FDA Clearance for N-GAGE Lumbar Plate System

2 months ago2 min read

Key Insights

  • Expanding Innovations received U.S. FDA 510(k) clearance for its N-GAGE Lumbar Plate System, marking the company's first spinal fixation platform.

  • The modular system offers spine surgeons a flexible fixation solution for lateral and anterolateral lumbar fusions using NON-SCREW-based technology.

  • The N-GAGE Plate uniquely pairs with the X-PAC LLIF Expandable Interbody Cage System via a NON-SCREW-based Polyaxial Coupler.

Expanding Innovations, a rapidly growing spine company specializing in NON-SCREW-based Expandable Technology, announced U.S. FDA 510(k) clearance for its N-GAGE Lumbar Plate System on June 18, 2025. This regulatory approval marks the company's first spinal fixation platform as it continues to broaden its procedure-based solutions.

Novel Fixation Technology

The modular, low-profile construct offers spine surgeons a flexible fixation solution for lateral and anterolateral lumbar fusions. The N-GAGE Plate uniquely pairs with the X-PAC LLIF Expandable Interbody Cage System via a NON-SCREW-based, Polyaxial Coupler. This first-of-its-kind connection simplifies plate-to-cage attachment and allows anatomical conformity to the vertebral bodies, mitigating the limitations of rigid, screw-based-attached lumbar plates.

Strategic Market Expansion

"This regulatory milestone not only reflects our ongoing commitment to solving persistent challenges that exist in spine surgery," said Ron Sacher, Executive Chairman and Co-Founder. "It represents the first of multiple upcoming technologies that will transition EI from a product-based technology company to a complete procedural solutions provider. N-GAGE unlocks new revenue opportunities and end-user value to complement our flagship, NON-SCREW-based X-PAC expandable technology platform."

Established Technology Platform

Expanding Innovations is an emerging medical device leader in expandable implant technology for spine surgery. The company developed its revolutionary, NON-SCREW-based expandable cage technology to address the need for a next-generation expandable interbody cage platform that would mitigate the incidence of post-op cage collapse and vertebral body subsidence.
The X-PAC Expandable Interbody Cages replace the traditional inner implant drive screw with a patented lift and lock expansion mechanism that provides exceptional tactile feedback to the surgeon throughout implant expansion and robust locking of the implant upon completion of expansion. With over 15,000 cages implanted, surgeon adoption and trust in X-PAC Expandable Interbody Cage technology continue to grow across the United States.

Future Development Pipeline

Expanding Innovations continues to innovate with significant technology advancements and planned expansion of its X-PAC Portfolio in 2026. The company's strategic launch of the N-GAGE system expands its procedural portfolio and strengthens its market position in the spine surgery sector.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.